A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
AK117 (Anti-CD47) + Anti-EGFR for R/M HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
- Status
- RECRUITING
- Phase
- PHASE3
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer
- Status
- SUSPENDED
- Phase
- NA
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of VET3-TGI in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE2
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2